Trial Profile
Long-term monitoring of safety in subjects treated with duloxetine for stress urinary incontinence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Stress incontinence
- Focus Adverse reactions
- 03 Aug 2006 Status change
- 16 Nov 2005 New trial record.